Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$614K Buy
2,471
+64
+3% +$15.3K 0.21% 73
2020
Q4
$553K Buy
2,407
+36
+2% +$8.3K 0.2% 73
2020
Q3
$603K Buy
2,371
+315
+15% +$78K 0.28% 56
2020
Q2
$485K Buy
+2,056
New +$469K 0.23% 66
2019
Q3
Sell
-325
Closed -$59.9K 77
2019
Q2
$59.9K Sell
325
-41
-11% -$7.34K 0.03% 176
2019
Q1
$70K Buy
+366
New +$69.9K 2.52% 11

Other funds holding AMGN

WealthStone's AMGN Position: Q1 2021 in Review

WealthStone increased its Amgen (AMGN) stake by 2.7% in Q1 2021, buying an estimated $15.3K and bringing the position to 2,471 shares worth $614K. The position accounts for 0.21% of the portfolio, ranked #73.

WealthStone first reported a position in AMGN in Q1 2019 and has held it in 6 quarters since. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • WealthStone held 2,471 shares of Amgen worth $614K as of Q1 2021.
  • WealthStone bought 64 Amgen shares in Q1 2021, an estimated $15.3K.
  • Amgen made up 0.21% of WealthStone's portfolio in Q1 2021, its #73 holding.
  • WealthStone first reported a position in Amgen in Q1 2019 and has held it in 6 quarters since.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on WealthStone's 13F filing for Q1 2021, filed 13 May 2021.